3VV: S-{(3R,5R,9R)-1-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaheptadecan-17-yl} (9Z)-octadec-9-enethioate (non-preferred name)
3VV is a Ligand Of Interest in 4PDK designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 4PDK_3VV_A_301 | 68% | 9% | 0.098 | 0.911 | 2.84 | 1.6 | 18 | 15 | 6 | 0 | 100% | 1 |
| 4PDK_3VV_B_301 | 43% | 8% | 0.157 | 0.88 | 2.85 | 1.72 | 20 | 16 | 10 | 0 | 100% | 0.84 |
| 4PDK_3VV_A_302 | 42% | 9% | 0.132 | 0.849 | 2.86 | 1.62 | 18 | 17 | 11 | 0 | 100% | 1 |
| 4PDK_3VV_B_302 | 33% | 8% | 0.139 | 0.816 | 2.91 | 1.67 | 19 | 17 | 10 | 0 | 100% | 1 |
| 8Y41_3VV_D_301 | 98% | 64% | 0.046 | 0.976 | 0.49 | 0.73 | 1 | 1 | 19 | 0 | 100% | 1 |
| 6WF2_3VV_A_403 | 76% | 9% | 0.1 | 0.94 | 2.92 | 1.49 | 20 | 15 | 17 | 0 | 100% | 1 |
